Tech Company Financing Transactions

Resolvyx Pharmaceuticals Funding Round

Resolvyx Pharmaceuticals secured a $25 million Series B funding round on 4/22/2008. Investors included Atlas Venture, Biogen Idec and CHL Medical Partners.

Transaction Overview

Company Name
Resolvyx Pharmaceuticals
Announced On
4/22/2008
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors

Atlas Venture (Jean-François Formela)

Biogen Idec

CHL Medical Partners (Gregory Weinhoff)

Flagship Pioneering (Douglas Levinson)

QVT Fund (Keith Manchester)

Radius Ventures (George Milne)

Proceeds Purpose
Proceeds from the financing will be used to accelerate the development of Resolvyx's preclinical pipeline and to advance multiple resolvin drug candidates into clinical trials in 2008.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25 1st St.
Cambridge, MA 02141
USA
Phone
(781) 541-5045
Website
www.resolvyx.com
Email Address
[email protected]
Overview
Resolvyx is a biopharmaceutical company committed to the discovery and development of therapies based on the novel concept of inflammation resolution through activation of the body's own off-switch mechanisms.
Profile
Resolvyx Pharmaceuticals LinkedIn Company Profile
Social Media
Resolvyx Pharmaceuticals Company Twitter Account
Company News
Resolvyx Pharmaceuticals News
Facebook
Resolvyx Pharmaceuticals on Facebook
YouTube
Resolvyx Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Greg Weinhoff
  Greg Weinhoff LinkedIn Profile  Greg Weinhoff Twitter Account  Greg Weinhoff News  Greg Weinhoff on Facebook
Chief Executive Officer
James Nichols
  James Nichols LinkedIn Profile  James Nichols Twitter Account  James Nichols News  James Nichols on Facebook
Chief Medical Officer
Per Gjorstrup
  Per Gjorstrup LinkedIn Profile  Per Gjorstrup Twitter Account  Per Gjorstrup News  Per Gjorstrup on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/22/2008: Argentis Pharmaceuticals venture capital transaction
Next: 4/22/2008: Celsense venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.